MiRNA profiling in pancreatic cancer and restoration of chemosensitivity

Saurabh Singh, Deepak Chitkara, Virender Kumar, Stephen W. Behrman, Ram I. Mahato

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Pancreatic cancers relapse due to small but distinct population of cancer stem cells (CSCs) which are in turn regulated by miRNAs. The present study identifies a series of miRNAs which were either upregulated (e.g. miR-146) or downregulated (e.g. miRNA-205, miRNA-7) in gemcitabine resistant MIA PaCa-2 cancer cells and clinical metastatic pancreatic cancer tissues. Gemcitabine resistant MIA PaCa-2 cells possessed distinct ALDH-positive CSC fraction expressing stem cell markers OCT3/4 and CD44 and chemoresistance marker class III. β-tubulin (TUBB3) which decreases on transfection with miR-205 resulting in the restoration of chemosensitivity to gemcitabine.

Original languageEnglish (US)
Pages (from-to)211-220
Number of pages10
JournalCancer Letters
Volume334
Issue number2
DOIs
StatePublished - Jul 1 2013

Fingerprint

gemcitabine
MicroRNAs
Pancreatic Neoplasms
Neoplastic Stem Cells
Tubulin
Transfection
Stem Cells
Down-Regulation
Recurrence
Population
Neoplasms

Keywords

  • Cancer stem cells
  • Chemoresistance
  • Gemcitabine
  • MiRNA
  • Pancreatic cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

MiRNA profiling in pancreatic cancer and restoration of chemosensitivity. / Singh, Saurabh; Chitkara, Deepak; Kumar, Virender; Behrman, Stephen W.; Mahato, Ram I.

In: Cancer Letters, Vol. 334, No. 2, 01.07.2013, p. 211-220.

Research output: Contribution to journalArticle

Singh, Saurabh ; Chitkara, Deepak ; Kumar, Virender ; Behrman, Stephen W. ; Mahato, Ram I. / MiRNA profiling in pancreatic cancer and restoration of chemosensitivity. In: Cancer Letters. 2013 ; Vol. 334, No. 2. pp. 211-220.
@article{fddca32a185348fea41378e338b83559,
title = "MiRNA profiling in pancreatic cancer and restoration of chemosensitivity",
abstract = "Pancreatic cancers relapse due to small but distinct population of cancer stem cells (CSCs) which are in turn regulated by miRNAs. The present study identifies a series of miRNAs which were either upregulated (e.g. miR-146) or downregulated (e.g. miRNA-205, miRNA-7) in gemcitabine resistant MIA PaCa-2 cancer cells and clinical metastatic pancreatic cancer tissues. Gemcitabine resistant MIA PaCa-2 cells possessed distinct ALDH-positive CSC fraction expressing stem cell markers OCT3/4 and CD44 and chemoresistance marker class III. β-tubulin (TUBB3) which decreases on transfection with miR-205 resulting in the restoration of chemosensitivity to gemcitabine.",
keywords = "Cancer stem cells, Chemoresistance, Gemcitabine, MiRNA, Pancreatic cancer",
author = "Saurabh Singh and Deepak Chitkara and Virender Kumar and Behrman, {Stephen W.} and Mahato, {Ram I.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.canlet.2012.10.008",
language = "English (US)",
volume = "334",
pages = "211--220",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - MiRNA profiling in pancreatic cancer and restoration of chemosensitivity

AU - Singh, Saurabh

AU - Chitkara, Deepak

AU - Kumar, Virender

AU - Behrman, Stephen W.

AU - Mahato, Ram I.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Pancreatic cancers relapse due to small but distinct population of cancer stem cells (CSCs) which are in turn regulated by miRNAs. The present study identifies a series of miRNAs which were either upregulated (e.g. miR-146) or downregulated (e.g. miRNA-205, miRNA-7) in gemcitabine resistant MIA PaCa-2 cancer cells and clinical metastatic pancreatic cancer tissues. Gemcitabine resistant MIA PaCa-2 cells possessed distinct ALDH-positive CSC fraction expressing stem cell markers OCT3/4 and CD44 and chemoresistance marker class III. β-tubulin (TUBB3) which decreases on transfection with miR-205 resulting in the restoration of chemosensitivity to gemcitabine.

AB - Pancreatic cancers relapse due to small but distinct population of cancer stem cells (CSCs) which are in turn regulated by miRNAs. The present study identifies a series of miRNAs which were either upregulated (e.g. miR-146) or downregulated (e.g. miRNA-205, miRNA-7) in gemcitabine resistant MIA PaCa-2 cancer cells and clinical metastatic pancreatic cancer tissues. Gemcitabine resistant MIA PaCa-2 cells possessed distinct ALDH-positive CSC fraction expressing stem cell markers OCT3/4 and CD44 and chemoresistance marker class III. β-tubulin (TUBB3) which decreases on transfection with miR-205 resulting in the restoration of chemosensitivity to gemcitabine.

KW - Cancer stem cells

KW - Chemoresistance

KW - Gemcitabine

KW - MiRNA

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=84878214589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878214589&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2012.10.008

DO - 10.1016/j.canlet.2012.10.008

M3 - Article

C2 - 23073476

AN - SCOPUS:84878214589

VL - 334

SP - 211

EP - 220

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -